Revlimid patient scheme ‘working’
December 14, 2012Sales and Marketing Celgene, Revlimid
Celgene has issued figures which it says demonstrate the clinical value of the NICE-agreed patient access scheme for its cancer …
David Stack appointed to Amarin Board of directors
December 14, 2012Manufacturing and Production, Research and Development, Sales and Marketing Amarin, David Stack
Biopharma firm Amarin has confirmed that David Stack, president and chief executive of Pacira Pharmaceuticals, has joined its Board of …
Board consults on specialised services
December 13, 2012Sales and Marketing CF, NHS CB, Sickle cell
The NHS Commissioning Board has launched a consultation into how the NHS provides specialised services, including treatments for conditions such …
‘Augmented reflection’ brings GAD to life
December 13, 2012Medical Communications GAD, Pfizer, You Tube
Pfizer has worked with patient group Anxiety UK to create a new ‘enhanced reflection’ video to raise awareness of Generalised …
Hold tight: a bumpy ride ahead for the NHS
December 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, NHS, Wallards, reforms
The Wellards Annual Conference is an event where two worlds – the industry and the NHS – meet for a …
Stevenage Bioscience Catalyst hires first entrepreneur-in-residence
December 13, 2012Manufacturing and Production, Research and Development, Sales and Marketing Stevenage Bioscience Catalyst
Early-stage biotech firm Stevenage Bioscience Catalyst (SBC) has appointed Dr Barbara Domayne-Hayman as its first entrepreneur-in-residence. Domayne-Hayman will work with …
Eliquis in UK for AF
December 13, 2012Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer
Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …
New managing director for Lilly UK
December 12, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly
Lilly UK has appointed Dr Jean-Michel Cosséry as the new managing director and VP of the UK Affiliate and the …
Almac Group appoints Charlie Morris to executive team
December 12, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almac Group
The Almac Group’s Clinical Technologies business unit has announced that Charlie Morris has joined the company as vice president of …
Switzerland first to pass EU’s ‘equivalence’ test for APIs
December 12, 2012Manufacturing and Production API, China, EU, FMD, MHRA
Switzerland has become the first country to be classed as having equivalent standards for the manufacture of active pharmaceutical ingredients …
Novartis blood cancer hope
December 12, 2012Research and Development, Sales and Marketing Jakavi, Novartis, oncology
Two-year data from Novartis’s drug Jakavi suggests that it may improve overall survival in a rare form of cancer versus …
Roche plans €200m investment in diagnostics facility
December 12, 2012Manufacturing and Production Diagnostics, Roche
Roche has said it intends to invest more than €200 million ($260m) in the construction of a new production plant …
SMC first to give Fycompa thumbs-up
December 12, 2012Sales and Marketing Eisai, Fycompa, SMC, Scotland, epilepsy
The Scottish Medicines Consortium (SMC) has approved Eisai’s first-in-class epilepsy drug Fycompa for use in the NHS in Scotland – …
Hanover Communications hires associate director
December 12, 2012Medical Communications, Sales and Marketing Hanover, Jim Baxter
Hanover Communications has announced the appointment of Jim Baxter to its Healthcare division in order to expand into the brand …
Contract research news in brief
December 12, 2012Research and Development AMRI, Covance, Dimensione Ricerca, INC Research, Perceptive Informatics, TFS
TFS buys Italian CRO Dimensione Ricerca, AMRI closes a US facility plus business development updates from Covance, Perceptive Informatics and …
EC approves new Xaluprine formulation
December 12, 2012Research and Development
The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl …
First CCGs get green light
December 11, 2012Sales and Marketing CB, CCGs, Hunt, Lansley, NHS
In a landmark development for the controversial Health and Social Care Act, the first clinical commissioning groups (CCGs) have taken …
USP postpones work on elemental impurities
December 11, 2012Manufacturing and Production
The US Pharmacopeial Convention (USP) has postponed the publication of new chapters on elemental impurities after an appeal by drugmakers …
Boehringer to make cancer antibody for Apexigen
December 11, 2012Manufacturing and Production, Sales and Marketing APX005, Apexigen, Boehringer
Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …
EMA sets out stall on medicine shortages
December 11, 2012Manufacturing and Production EMA, GMP, shortages
The European Medicines Agency has called for action at the EU level to tackle the issue of medicine shortages caused …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
